Loading clinical trials...
Loading clinical trials...
A First-in-human, Phase I Study of Evaluating Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of AK138D1 in the Treatment of Advanced Solid Tumors
Conditions
Interventions
AK138D1
Locations
4
Australia
Blacktown Hospital-Blacktwon Cancer and Haematology Centre
Blacktown, New South Wales, Australia
Macquarie University
North Ryde, New South Wales, Australia
ICON Cancer Centre South Brisbane
South Brisbane, Queensland, Australia
Peninsula & South Eastern Haematology and Oncology Group
Frankston, Victoria, Australia
Start Date
February 24, 2025
Primary Completion Date
February 26, 2028
Completion Date
August 30, 2028
Last Updated
March 6, 2025
NCT07186842
NCT03514368
NCT07371663
NCT07161310
NCT07114627
NCT06666270
Lead Sponsor
Akeso
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions